In addition, MEG3 affected the epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR; low levels of MEG3 and miR-219a-5p were associated with a poor prognosis in patients with ovarian cancer (Figure 3). The gene discussed is MEG3; the disease is ovarian carcinoma.